Rubric :   Chemotherapy of solid tumors

Concurrent chemoendocrine therapy in patients with prevailing breast cancer
Authors: Tymovska Y.O. Zotov A.S. №3(19) 2015
Acetylsalicylic acid as an agent of breast cancer chemoprevention (review)
Authors: Vereshchako R.I. Zotov A.S. Samusieva A.A. №1(17) 2015
The treatment of cytostatic-induced neuropathy in using Meditan in cancer patients
Authors: Schevnya S.P. Matsyshevskaya I.V. Schnaiderman P.Y. №1(17) 2015
Breast cancer prognostic factors. Current state of the problem
Authors: Sivak L.A. Verevkina N. Lyalkin S. №4(16) 2014
The digest of scientific-research workshop for oncologists «Prophylaxis and treatment of chemotherapy complications (hematological toxicity)»
Authors: Gubareva G.O. Filonenko K.S. Aleksik О.М. №4(16) 2014
Neoadjuvant chemotherapy of cervical cancer carcinoma stage IIB — the guarantee of radical surgical intervention
Authors: Lukyanchuk O.V. Kuznetsova O.V. №4(16) 2014
Pharmacoeconomic analysis of anticancer drugs use for prostate cancer treatment
Authors: Education Postgraduate of Academy Medical National Shupyk University P.L. Medical National Lviv Halytsky Danylo Kyiv №3(15) 2014
The digest of scientific-research workshop «Prophylaxis and treatment of chemotherapy complications (hepatotoxicity)» for oncologists, which are conducting chemotherapy
Authors: Gubareva G.O. Filonenko K.S. Aleksik О.М. №3(15) 2014
Prognosis of breast cancer course by identifying gene intersektyn ITSN2
Authors: Sivak L.A. Kryachok I. Gubareva G.O. Lyalkin S.... №3(15) 2014
Chemotherapy and targeted therapy combination in patients with platinum-resistant ovarian cancer: case report
Authors: Kuznetsova O.V. Tchebotariova Rybin,G.M. Marzynkivska,A.I. N.V. Rybin A.I. №3(15) 2014
Correction of neurological side effects of taxanes by Meditan in patients with breast cancer
Authors: Musa E.N. Odarchenko N.Y. №2(14) 2014
Oncofertility and breast cancer. Decision making algorithm before starting treatment
Authors: Feskov A.M. Kartashov S.M. Safonov R.A. Blagoveschenschky E.V.... №3(15) 2014
Erlotinib (Tarceva) as first-line treatment for patients with non-small cell lung cancer with EGFR mutations: analysis of effectiveness
№1(13) 2014
Effectiveness of support therapy algorithms based on chemotherapy toxicity prognostic factors in patients with breast cancer
Authors: Sivak L.A. Gubareva G.O. Lyalkin S. Mаydаnеvich N.... №1(13) 2014
Modern principles of adjuvant treatment of breast cancer
Authors: Kryachok I. Gubаrеvа А.А. Aleksyk O.M. Filonenko Е. №2(10) 2013

123